Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PRME

Prime Medicine Inc

Feb 09 • 01:47PM ET

3.53

-0.04 -1.25 %

Healthcare • Biotechnology • USA • NASD

Peers: CRSP NTLA EDIT BEAM ALLO VERV DNLI IGMS PSTX SANA

| Held by: ARKG XBI VTI IWM VXF IWN IBB SCHA VTWO VFMO

Index	RUT	P/E	-	EPS (ttm)	-1.48	Insider Own	48.03%	Shs Outstand	180.31M	Perf Week	-7.23%
Market Cap	636.37M	Forward P/E	-	EPS next Y	-0.93	Insider Trans	0.00%	Shs Float	93.82M	Perf Month	-10.07%
Enterprise Value	541.22M	PEG	-	EPS next Q	-0.25	Inst Own	42.15%	Short Float	28.03%	Perf Quarter	-15.66%
Income	-197.34M	P/S	106.42	EPS this Y	19.76%	Inst Trans	27.88%	Short Ratio	7.09	Perf Half Y	-6.86%
Sales	5.98M	P/B	3.93	EPS next Y	30.06%	ROA	-54.98%	Short Interest	26.30M	Perf YTD	1.60%
Book/sh	0.90	P/C	2.98	EPS next 5Y	20.13%	ROE	-112.34%	52W High	6.94 -49.20%	Perf Year	39.90%
Cash/sh	1.18	P/FCF	-	EPS past 3/5Y	4.95% -124.13%	ROIC	-72.49%	52W Low	1.11 217.60%	Perf 3Y	-82.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-19.83%	Volatility	9.90% 8.99%	Perf 5Y	-
Dividend TTM	-	EV/Sales	90.50	EPS Y/Y TTM	26.79%	Oper. Margin	-3412.48%	ATR (14)	0.34	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.61	Sales Y/Y TTM	647.12%	Profit Margin	-3301.64%	RSI (14)	43.11	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	6.61	EPS Q/Q	28.12%	SMA20	-11.42%	Beta	2.72	Target Price	6.41
Payout	-	Debt/Eq	0.73	Sales Q/Q	486.12%	SMA50	-8.46%	Rel Volume	0.42	Prev Close	3.57
Employees	214	LT Debt/Eq	0.68	Earnings	Nov 07 BMO	SMA200	-2.03%	Avg Volume	3.71M	Price	3.53
IPO	Oct 20, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	-26.53% -52.54%	Trades		Volume	1,044,877	Change	-1.25%

Date	Action	Analyst	Rating Change	Price Target Change
May-27-25	Downgrade	Citigroup	Buy → Neutral	$1.50
May-20-25	Downgrade	JP Morgan	Overweight → Neutral
May-20-25	Downgrade	H.C. Wainwright	Buy → Neutral
Dec-10-24	Initiated	JMP Securities	Mkt Outperform	$10
May-20-24	Initiated	H.C. Wainwright	Buy	$10
May-16-24	Upgrade	Citigroup	Neutral → Buy	$10
Apr-22-24	Initiated	Chardan Capital Markets	Buy	$17
Apr-08-24	Initiated	TD Cowen	Buy
Apr-03-24	Initiated	Wedbush	Outperform	$12
Jan-16-24	Downgrade	Stifel	Buy → Hold	$18 → $9
Dec-08-23	Initiated	Citigroup	Neutral	$10
Oct-09-23	Initiated	BMO Capital Markets	Outperform	$19
Jul-31-23	Initiated	Guggenheim	Buy	$24
Apr-18-23	Initiated	Stifel	Buy	$18
Nov-14-22	Initiated	Morgan Stanley	Equal-Weight	$23
Nov-14-22	Initiated	JP Morgan	Overweight	$27
Nov-14-22	Initiated	Jefferies	Buy	$25
Nov-14-22	Initiated	Goldman	Neutral	$22

Show Previous Ratings

Jan-07-26 08:00AM	Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +9.19%
Jan-02-26 01:29PM	Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize (PR Newswire)
Dec-31-25 11:12AM	LifeSci Capital Initiates Prime Medicine (PRME), Highlights One-and-Done Potential in Liver and Lung Diseases (Insider Monkey)
Dec-30-25 11:45PM	Prime Medicine, Inc. (PRME) Announces NEJM Publication Of PM359 Data (Insider Monkey)
Dec-07-25 08:05AM	Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease (GlobeNewswire)
08:00AM	Loading…
Nov-25-25 08:00AM	Prime Medicine to Present at 8th Annual Evercore Healthcare Conference (GlobeNewswire)
Nov-11-25 08:00AM	Prime Medicine to Present at Jefferies Global Healthcare Conference (GlobeNewswire) +11.21%
Nov-07-25 10:21AM	CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire) -8.85%
08:10AM	Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-03-25 08:01AM	Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer (GlobeNewswire) -7.69%
Oct-30-25 04:01PM	Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy (GlobeNewswire) +13.56%
08:20AM	NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Oct-07-25 08:28PM	Lightning Round: Shopify is going much higher, says Jim Cramer (CNBC TV) +9.88%
08:00AM	Prime Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
04:50PM	Loading…
Sep-15-25 04:50PM	Why Cathie Wood is Loading Up on These 2 Growth Stocks (And Should You?) (Barchart) +16.46%
Aug-26-25 08:00AM	Prime Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-07-25 09:10AM	Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -9.58%
08:00AM	Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-01-25 04:01PM	Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire) +8.02% +11.39%
Jul-31-25 11:40PM	JonesTrading Maintains a Buy on Prime Medicine (PRME) (Insider Monkey)
Jul-30-25 09:33PM	Prime Medicine Announces Pricing of Public Offering (GlobeNewswire)
04:01PM	Prime Medicine Announces Proposed Public Offering of Common Stock (GlobeNewswire)
09:55AM	Prime Medicine, Inc. (PRME) Now Trades Above Golden Cross: Time to Buy? (Zacks)
09:44AM	3 Genomics Stocks Worth Adding to Your Portfolio in 2025 (Zacks)
Jul-20-25 12:35AM	BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT (Insider Monkey)
Jul-16-25 08:10AM	Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy (Business Wire) -5.83%
07:00AM	Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis (GlobeNewswire)
Jul-07-25 12:48PM	Prime Medicine stock soars amid gene editing sector momentum (Investing.com) +22.19%
Jul-06-25 04:01AM	Prime Medicine Focuses on Genetic Liver Diseases, Partnered Programs After Positive CGD Data (Insider Monkey)
08:00AM	Loading…
May-29-25 08:00AM	Prime Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-27-25 02:24PM	Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty (Insider Monkey)
May-22-25 12:35PM	Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More (Zacks) +5.58%
May-19-25 08:31AM	Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition (GlobeNewswire) -16.04%
08:30AM	Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease (GlobeNewswire)
08:28AM	Prime Medicine claims proof of concept, but lays off staff in pivot (BioPharma Dive)
May-08-25 09:25AM	Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -7.04%
08:00AM	Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire)
May-07-25 05:10PM	Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.77%
May-05-25 08:25AM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.55%
Apr-25-25 10:51AM	Prime Medicine: Initiating Coverage At Hold With 2025 Binary Catalyst For PM359 (Seeking Alpha)
Apr-01-25 11:50AM	Biotech stocks slide as Marks resignation seen being negative for sector (TipRanks) -10.30%
Mar-20-25 06:48PM	Why Prime Medicine Stock Was Climbing Higher This Week (Motley Fool)
Mar-19-25 02:56PM	Why Prime Medicine Stock Is Soaring Today (Fool) +13.64%
Mar-18-25 08:09AM	Prime sets sights on liver, lung disease as next target for its gene editing tech (BioPharma Dive)
07:00AM	Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) (GlobeNewswire)
Feb-28-25 08:00AM	Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-24-25 08:00AM	Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Jan-07-25 08:00AM	Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-31-24 01:00PM	Is Prime Medicine (PRME) Among the Top CRISPR Stocks to Invest In? (Insider Monkey) +5.04%
Dec-30-24 02:46PM	Why Prime Medicine (PRME) Is One of the Best Biotech Penny Stocks to Invest in Now? (Insider Monkey)
Dec-29-24 06:25AM	Prime Medicine, Inc. (PRME): Is This Gene Therapy Stock a Good Buy Right Now? (Insider Monkey)
Nov-12-24 04:00PM	Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) -8.33%
Nov-06-24 04:00PM	Prime Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-28-24 10:00AM	12 High-Growth Stocks That Could Deliver Parabolic Returns (Motley Fool)
Oct-24-24 08:00AM	Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress (GlobeNewswire) +5.26%
Oct-16-24 09:45AM	Why I Keep Buying These 14 Incredible Growth Stocks (Motley Fool) +5.04%
Oct-15-24 08:00AM	Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings (GlobeNewswire)
Oct-01-24 09:33AM	BMS and Prime ink potential $3.5bn deal to develop T cell therapies (Pharmaceutical Technology) -10.85%
Sep-30-24 06:08PM	Why Prime Medicine Stock Soared Nearly 12% Higher on Monday (Motley Fool) +11.85%
08:38AM	Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline (Benzinga)
07:01AM	Prime Medicine Unveils Strategically Focused Pipeline (GlobeNewswire)
07:00AM	Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies (GlobeNewswire)
06:30AM	Prime to narrow gene editing research as it strikes deal with Bristol Myers (BioPharma Dive)
Aug-28-24 08:15AM	2 Growth Stocks That Could Make You Richer (Motley Fool)
08:00AM	Prime Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-08-24 08:00AM	Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Jul-31-24 01:53PM	Prime Medicine (PRME) Stock: Buy or Sell Before Q2 Earnings? (Zacks)
Jul-19-24 10:00AM	Prime Medicine (PRME) Gains 16.4% in 3 Months: Buy Now or Wait? (Zacks)
Jul-08-24 05:44PM	Prime Medicine, Inc. (PRME): Why Do Analysts Love This Shorted Stock Right Now? (Insider Monkey)
12:30PM	10 Most Shorted Stocks That Are Loved by Analysts (Insider Monkey)
May-30-24 09:55AM	Wall Street Analysts Believe Prime Medicine, Inc. (PRME) Could Rally 120.95%: Here's is How to Trade (Zacks)
08:00AM	Prime Medicine to Present at Upcoming Investor Conferences (GlobeNewswire)
May-29-24 06:30AM	If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names (InvestorPlace)
May-25-24 04:10AM	Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio (Motley Fool)
May-20-24 09:32PM	Cathie Wood Pulls the Trigger on These 2 Strong Buy Stocks (TipRanks) +6.36% +6.64%
09:33AM	HC Wainwright Starts Coverage on Prime Medicine With Buy Rating, $10 Price Target (MT Newswires)
May-17-24 06:27AM	Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 (InvestorPlace)
06:15AM	Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 (InvestorPlace)
May-16-24 07:14AM	Citigroup Upgrades Prime Medicine at Buy From Neutral With $10 Price Target (MT Newswires)
May-14-24 09:55AM	Does Prime Medicine, Inc. (PRME) Have the Potential to Rally 133.64% as Wall Street Analysts Expect? (Zacks)
May-13-24 11:12AM	JPMorgan Adjusts Price Target on Prime Medicine to $15 From $16, Keeps Overweight Rating (MT Newswires) +14.44%
08:00AM	Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire)
May-12-24 03:00AM	Alphabet Bought Up Two Slumping Stocks (Barrons.com)
May-10-24 02:23PM	Prime Medicine Inc (PRME) Q1 2024 Earnings: Navigates Through Challenges with Strategic Developments (GuruFocus.com)
01:53PM	PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024 (InvestorPlace)
08:00AM	Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
May-08-24 08:00AM	Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD) (GlobeNewswire)
May-03-24 12:00PM	What Makes Prime Medicine, Inc. (PRME) a New Buy Stock (Zacks)
May-01-24 08:00AM	Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference (GlobeNewswire) +7.11%
Apr-30-24 06:01AM	Prime Medicine gets green light for trials of first-ever prime editing drug (Clinical Trials Arena)
Apr-29-24 10:12AM	Prime Medicine Shares Jump After Application for Chronic Granulomatous Disease Treatment Gets FDA Clearance (MT Newswires) +9.83%
07:35AM	Prime gets FDA green light to begin first trial test of prime editing (BioPharma Dive)
07:33AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
07:00AM	Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) (GlobeNewswire)
Apr-23-24 08:00AM	Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings (GlobeNewswire)
Mar-27-24 08:45AM	2 Magnificent Growth Stocks With Room to Run (Motley Fool)
Mar-14-24 02:44PM	Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging (InvestorPlace) -13.18%
Mar-01-24 02:00PM	Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? (InvestorPlace)
08:00AM	Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GV 2021 GP, L.L.C.	10% Owner	Aug 01 '25	Buy	3.30	1,500,000	4,950,000	3,262,440	Aug 05 04:07 PM
NELSEN ROBERT	Director	Aug 01 '25	Buy	3.30	3,030,300	9,999,990	6,230,300	Aug 01 07:19 PM
ARCH Venture Partners XII, LLC	10% Owner	Aug 01 '25	Buy	3.30	3,030,300	9,999,990	6,230,300	Aug 01 07:19 PM
ARCH Venture Partners X, LLC	10% Owner	Aug 01 '25	Buy	3.30	3,030,300	9,999,990	6,230,300	Aug 01 07:18 PM
Liu David R.	10% Owner	Jun 30 '25	Buy	2.52	21,000	52,830	20,240,945	Jul 01 04:03 PM
Liu David R.	10% Owner	Jun 23 '25	Buy	2.16	21,000	45,402	20,219,945	Jun 23 04:33 PM
Liu David R.	10% Owner	Jun 16 '25	Buy	1.49	21,000	31,196	20,198,945	Jun 16 05:14 PM
Liu David R.	10% Owner	Jun 11 '25	Buy	1.60	21,000	33,590	20,177,945	Jun 12 04:49 PM
Brudnick Richard	Chief Business Officer	May 20 '25	Buy	1.19	20,000	23,790	20,000	May 22 04:22 PM
LEE ANN L.	Chief Technical Officer	May 21 '25	Buy	1.13	100,000	113,000	100,000	May 22 04:21 PM
Reine Allan	Chief Executive Officer	May 21 '25	Buy	1.18	125,000	147,150	125,000	May 22 04:18 PM

Open in Screener

SANA

Sana Biotechnology Inc

Feb 09 • 01:47PM ET

3.94

+0.01 0.38 %

Healthcare • Biotechnology • USA • NASD

SANA Sana Biotechnology Inc daily Stock Chart

Peers: VERV PRME NTLA EDIT TSHA CRBU CABA BEAM MGTX PGEN

| Held by: VTI XBI IWM VXF IWN IBB VTWO SCHA VHT PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.97	Insider Own	37.73%	Shs Outstand	262.26M	Perf Week	-14.05%
Market Cap	1.05B	Forward P/E	-	EPS next Y	-0.56	Insider Trans	0.00%	Shs Float	165.85M	Perf Month	-12.72%
Enterprise Value	975.81M	PEG	-	EPS next Q	-0.14	Inst Own	47.70%	Short Float	22.38%	Perf Quarter	-2.59%
Income	-234.41M	P/S	-	EPS this Y	25.60%	Inst Trans	4.94%	Short Ratio	9.76	Perf Half Y	31.50%
Sales	0.00M	P/B	5.30	EPS next Y	35.22%	ROA	-47.13%	Short Interest	37.11M	Perf YTD	-3.07%
Book/sh	0.74	P/C	6.68	EPS next 5Y	19.30%	ROE	-96.11%	52W High	6.55 -39.77%	Perf Year	21.01%
Cash/sh	0.59	P/FCF	-	EPS past 3/5Y	18.55% -10.60%	ROIC	-89.07%	52W Low	1.26 213.10%	Perf 3Y	-19.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.43% 7.71%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	31.16%	Oper. Margin	-	ATR (14)	0.34	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.55	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	40.79	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	4.55	EPS Q/Q	36.45%	SMA20	-12.77%	Beta	1.98	Target Price	8.17
Payout	-	Debt/Eq	0.42	Sales Q/Q	-	SMA50	-12.73%	Rel Volume	0.50	Prev Close	3.93
Employees	194	LT Debt/Eq	0.35	Earnings	Nov 06 AMC	SMA200	7.01%	Avg Volume	3.80M	Price	3.94
IPO	Feb 04, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	15.25% -	Trades		Volume	1,282,078	Change	0.38%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-24-25	Initiated	Wedbush	Outperform	$5
Jul-03-25	Resumed	Morgan Stanley	Overweight	$12
Mar-18-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$5
Mar-14-25	Initiated	Jefferies	Buy	$7
Jan-08-25	Upgrade	TD Cowen	Hold → Buy
Nov-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-26-24	Initiated	Rodman & Renshaw	Buy	$16
Jan-16-24	Upgrade	H.C. Wainwright	Neutral → Buy	$12
Sep-25-23	Initiated	JMP Securities	Mkt Outperform	$9
Sep-05-23	Initiated	Citigroup	Buy	$8
Aug-14-23	Initiated	TD Cowen	Market Perform
May-02-23	Initiated	H.C. Wainwright	Neutral
Mar-01-21	Initiated	Morgan Stanley	Overweight	$40
Mar-01-21	Initiated	JP Morgan	Neutral	$35
Mar-01-21	Initiated	Goldman	Neutral	$40
Mar-01-21	Initiated	BofA Securities	Buy	$45

Show Previous Ratings

Jan-30-26 12:00PM	Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know (Zacks)
Jan-23-26 09:55AM	Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet (Zacks)
Jan-07-26 04:26PM	Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +8.49%
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +7.39%
Dec-28-25 10:05AM	Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication (Insider Monkey)
09:00AM	Loading…
Dec-08-25 09:00AM	Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform (GlobeNewswire) -9.75%
Nov-28-25 10:11AM	Sana (SANA) Surges 14.5% Ahead of Business Announcements (Insider Monkey) +6.97%
Nov-24-25 04:05PM	Sana Biotechnology to Present at December 2025 Investor Conferences (GlobeNewswire) +7.60%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks)
06:17AM	Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength (Insider Monkey)
Nov-12-25 12:00PM	All You Need to Know About Sana (SANA) Rating Upgrade to Buy (Zacks)
Nov-06-25 04:26PM	Sana: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Nov-04-25 04:05PM	Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit (GlobeNewswire) -9.19%
Oct-15-25 12:07PM	Progressive stock sinks on Q3 miss, gold hits yet another record (Yahoo Finance Video) +33.03%
10:45AM	Loading…
10:45AM	Sana Biotechnology stock higher after Eric Jackson touts 100-bagger potential (Investing.com)
Sep-20-25 02:43AM	Sana Biotechnology Inc. (SANA) Bolsters Management Team (Insider Monkey)
Sep-17-25 02:18PM	Can Sana Biotechnology's (SANA) Pipeline Momentum Translate into More Share Price Upside? (Insider Monkey)
Sep-15-25 07:30AM	3 Stocks to Buy Under $10 That Could Triple From Here (Barchart)
Sep-08-25 12:30AM	JMP Securities Keeps Market Outperform Rating on Sana Biotechnology (SANA) (Insider Monkey)
Aug-26-25 04:05PM	Sana Biotechnology to Present at September 2025 Investor Conferences (GlobeNewswire)
Aug-25-25 11:56PM	Citizens JMP Reiterates a Buy Rating on Sana Biotechnology (SANA) With a $5 PT (Insider Monkey) -6.42%
Aug-20-25 04:05PM	Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Aug-12-25 11:43AM	Sana Biotech Bails on Factory in Old AT&T Call Center (IEN) +6.51%
Aug-11-25 06:11PM	Sana: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Aug-07-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) -30.12%
Aug-06-25 11:24PM	Sana Biotechnology Announces Pricing of Public Offering (GlobeNewswire)
04:38PM	Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
07:00AM	Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire)
11:35AM	Loading…
Aug-04-25 11:35AM	Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes (GlobeNewswire) +8.18%
Aug-01-25 06:47AM	Sana Biotechnology (SANA) Rated 'Market Perform' on Diabetes Program Prospects (Insider Monkey)
Jul-31-25 11:40PM	Citi Remains Bullish on Sana Biotechnology (SANA) (Insider Monkey) -6.88%
Jul-23-25 11:25AM	Citi Maintained a Buy Rating on Sana Biotechnology (SANA) (Insider Monkey) +5.54%
Jul-11-25 07:11PM	Sana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan Stanley (Insider Monkey)
Jul-03-25 09:09AM	Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting (Insider Monkey) +9.25%
Jun-24-25 03:51PM	BofA Remains Bullish on Sana Biotechnology (SANA) (Insider Monkey) +14.23%
Jun-23-25 10:05AM	Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression (GlobeNewswire)
Jun-09-25 04:05PM	Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions (GlobeNewswire)
May-28-25 04:05PM	Sana Biotechnology to Present at June 2025 Investor Conferences (GlobeNewswire) +12.50%
May-12-25 04:05PM	Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference (GlobeNewswire) +9.89% -10.25%
May-08-25 04:42PM	Sana: Q1 Earnings Snapshot (Associated Press Finance) +6.47%
04:05PM	Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
May-06-25 10:12PM	Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development (PR Newswire) -8.56%
Apr-29-25 08:00AM	Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics (PR Newswire)
Apr-24-25 06:00AM	Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare (PR Newswire)
Apr-22-25 05:45AM	Sana Biotechnology, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - SANA (PR Newswire) +8.81%
Apr-21-25 12:56PM	Sana Biotechnology, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights SANA (GlobeNewswire)
Apr-16-25 11:23AM	Is Sana Biotechnology Inc. (NASDAQ:SANA) the Best Biotech Penny Stock to Buy According to Hedge Funds? (Insider Monkey) -7.06%
Apr-10-25 12:39PM	Investors in Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights SANA (GlobeNewswire)
Apr-01-25 08:00AM	Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease (PR Newswire) -10.71%
Mar-25-25 08:00AM	Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica, an AI-Powered Drug Discovery Platform (Business Wire) -11.16%
Mar-24-25 11:45PM	Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421 (SeekingAlpha)
Mar-17-25 04:14PM	Sana: Q4 Earnings Snapshot (Associated Press Finance) -5.46% -17.69%
04:05PM	Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates (GlobeNewswire)
Mar-04-25 04:04PM	Is Sana Biotechnology (SANA) Among Jeff Bezos Investments in 2025? (Insider Monkey) +5.35%
Mar-01-25 06:02PM	Why Sana Biotechnology, Inc. (SANA) is Skyrocketing So Far in 2025 (Insider Monkey)
Feb-24-25 04:05PM	Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference (GlobeNewswire) -10.07%
Jan-28-25 10:42AM	Sana Biotechnology, Inc. (SANA): A Bull Case Theory (Insider Monkey)
Jan-22-25 07:59AM	Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025? (Insider Monkey) +19.86%
Jan-08-25 04:05PM	Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +160.61% -14.88%
10:34AM	Sana Biotechnology (SANA), eBay (EBAY) Are Among Todays Big Winners (Insider Monkey)
10:11AM	This Biotech Stock Soared 300% Overnight. Why It Can Go Higher. (Barrons.com)
07:26AM	Sana Biotechnology price target lowered to $7 from $8 at BofA (TipRanks)
07:25AM	This Biotech Stock Just Soared 240%. Why It Can Go Higher. (Barrons.com)
06:31AM	Tenvie raises $200M for brain drug R&D; Sana spikes on single patients results (BioPharma Dive)
Jan-07-25 04:05PM	Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression (GlobeNewswire) -5.71%
Dec-02-24 09:00AM	Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus (GlobeNewswire)
Nov-25-24 04:05PM	Sana Biotechnology to Present at December 2024 Investor Conferences (GlobeNewswire)
Nov-20-24 08:00AM	Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies (PR Newswire) +7.20%
06:30AM	Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer (PR Newswire)
Nov-13-24 09:55AM	Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher (Zacks) -6.34%
08:00AM	Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio (PR Newswire)
08:00AM	Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner (PR Newswire)
Nov-11-24 09:35AM	Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround (Zacks)
Nov-08-24 09:10AM	Sana: Q3 Earnings Snapshot (Associated Press Finance)
09:00AM	Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
Nov-05-24 04:40AM	Sana to lay off staff, deepen autoimmune focus in latest retrenchment (BioPharma Dive) -9.84%
Nov-04-24 04:30PM	Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 (GlobeNewswire)
Oct-23-24 08:00AM	Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence (PR Newswire)
Oct-16-24 08:58AM	Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts (Insider Monkey)
Oct-13-24 04:48PM	Sana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now (Insider Monkey)
Oct-09-24 07:00AM	Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions (PR Newswire)
Oct-03-24 08:00AM	Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors (PR Newswire)
Sep-30-24 04:05PM	Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference (GlobeNewswire)
Sep-26-24 06:00AM	Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry (PR Newswire) +13.56%
Aug-29-24 04:05PM	Sana Biotechnology to Present at September 2024 Investor Conferences (GlobeNewswire)
Aug-28-24 06:30AM	Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer (PR Newswire)
Aug-26-24 04:05PM	Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer (GlobeNewswire)
Aug-08-24 05:03PM	Sana: Q2 Earnings Snapshot (Associated Press Finance) +5.36%
04:05PM	Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
Aug-06-24 06:30AM	Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner (PR Newswire)
Jul-29-24 07:00AM	GSK and Flagship Pioneering partner to discover novel medicines and vaccines (PR Newswire)
Jul-25-24 08:00AM	Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World (PR Newswire)
Jul-23-24 06:00AM	Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class (PR Newswire)
Jul-17-24 08:00AM	Alltrna Announces Updates to Its Board of Directors (PR Newswire) -7.00%
Jul-10-24 06:00AM	Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability (PR Newswire)
06:00AM	Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions (PR Newswire)
Jun-12-24 07:00AM	Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer (PR Newswire)
May-21-24 09:00AM	Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington's Disease and Other Glial-based Neurodegenerative Conditions (GlobeNewswire)

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wyrick Susan D.	See Remarks	Jan 02 '26	Option Exercise	0.00	7,500	0	188,290	Jan 06 04:18 PM
Wyrick Susan D.	See Remarks	Dec 13 '25	Option Exercise	0.00	3,400	0	181,663	Dec 16 04:16 PM
Wyrick Susan D.	See Remarks	Dec 03 '25	Option Exercise	0.00	10,000	0	180,828	Dec 05 05:04 PM
Wyrick Susan D.	See Remarks	Jun 03 '25	Option Exercise	0.00	10,000	0	170,395	Dec 05 05:04 PM
Wyrick Susan D.	See Remarks	Mar 07 '25	Option Exercise	0.00	3,250	0	158,231	Mar 10 08:13 PM
Cassidy Bernard J	EVP & General Counsel	Mar 07 '25	Option Exercise	0.00	11,041	0	115,823	Mar 10 08:12 PM
Harr Steve	President & CEO	Mar 07 '25	Option Exercise	0.00	50,000	0	7,889,750	Mar 10 08:12 PM
Wyrick Susan D.	See Remarks	Mar 02 '25	Option Exercise	0.00	1,525	0	155,471	Mar 03 07:28 PM
CHRISTIAN HORDO & KATHARINE HO	Officer	Feb 18 '25	Proposed Sale	3.16	75,000	237,000		Feb 18 04:27 PM

PRME

Prime Medicine Inc

SANA

Sana Biotechnology Inc

Upgrade your FINVIZ experience